Search results

calcipotriol + betamethasone (Enstilar)

Topical treatment of psoriasis vulgaris in adults.

Calcipotriol and betamethasone ointment (Dovobet®)

Stable plaque psoriasis vulgaris amenable to topical therapy

betamethasone valerate 2.25mg medicated plaster (Betesil)

Inflammatory skin disorders which do not respond to treatment with less potent corticosteroids.

calcipotriol 50 mcg/g / betamethasone 05 mg/g (Xamiol Gel®)

Topical treatment of scalp psoriasis

Calcipotriol and bethamethasone ointment (Dovobet®)

Stable plaque psoriasis vulgaris amenable to topical therapy

dexamethasone (Ozurdex)

for the treatment of adult patients with macular oedema following either branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO).

dexamethasone (Ozurdex)

Treatment of adult patients with visual impairment due to diabetic macular oedema who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy.

levofloxacin plus dexamethasone (Ducressa)

Prevention and treatment of inflammation, and prevention of infection associated with cataract surgery in adults. Consideration should be given to official guidance on the appropriate use of antibacterial agents.  

dexamethasone 40mg tablets (Neofordex)

In adults for the treatment of symptomatic multiple myeloma in combination with other medicinal products

dexamethasone (Ozurdex)

Treatment of adult patients with inflammation of the posterior segment of the eye presenting as non-infectious uveitis.

ciprofloxacin 3mg/mL + dexamethasone 1mg/mL ear drops (Cilodex)

for treatment of the following infections in adults and children: Acute otitis media in patients with tympanostomy tubes (AOMT), Acute otitis externa

daratumumab (Darzalex)

In combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

daratumumab (Darzalex)

In combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

bortezomib (Velcade)

In combination with dexamethasone, or with dexamethasone and thalidomide, for the induction treatment of adult patients with previously untreated multiple myeloma who are eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.

carfilzomib (Kyprolis)

in combination with dexamethasone alone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.